Insulin glargine is a type of insulin. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus (sugar diabetes), your body does not produce enough insulin, or the insulin produced is not used properly. This causes you to have too much sugar in your blood. Like other types of insulin, insulin glargine is used to keep your blood sugar level close to normal. Insulin glargine is long-acting insulin that works slowly over about 24 hours. You may have to use insulin glargine in combination with another type of insulin or with a type of oral diabetes medicine to keep your blood sugar under control.

Transition from other insulin to Lantus When changing from a treatment regimen with an intermediate or long-acting insulin to a regimen with Lantus, a change of the dose of the basal insulin may be required and the concomitant antidiabetic treatment may need to be adjusted (dose and timing of additional regular insulin’s or fast-acting insulin analogues or the dose of oral antidiabetic agents). To reduce the risk of nocturnal and early morning hypoglycaemia, patients who are changing their basal insulin regimen from a twice daily NPH insulin to a once daily regimen with Lantus should reduce their daily dose of basal insulin by 20-30% during the first weeks of treatment. During the first weeks the reduction should, at least partially, be compensated by an increase in mealtime insulin, after this period the regimen should be adjusted individually. As with other insulin analogues, patients with high insulin doses because of antibodies to human insulin may experience an improved insulin response with Lantus. Close metabolic monitoring is recommended during the transition and in the initial weeks thereafter. With improved metabolic control and resulting increase in insulin sensitivity a further adjustment in dosage regimen may become necessary. Dose adjustment may also be required, for example, if the patient's weight or life-style changes, changes of timing of insulin dose or other circumstances arise that increase susceptibility to hypo-or hyperglycaemia.

AdministrationLantus is administered subcutaneously. Lantus should not be administered intravenously. The prolonged duration of action of Lantus is dependent on its injection into subcutaneous tissue. Intravenous administration of the usual subcutaneous dose could result in severe hypoglycaemia.

Interaction:

A number of substances affect glucose metabolism and may require dose adjustment of insulin glargine. Substances that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia include oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, propoxyphene, salicylates and sulphonamide antibiotics. Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens, phenothiazine derivatives, somatropin, sympathomimetic agents (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, atypical antipsychotic medicinal products (e.g. clozapine and olanzapine) and protease inhibitors. Beta-blockers, clonidine, lithium salts or alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin. Pentamidine may cause hypoglycaemia, which may sometimes be followed by hyperglycaemia. In addition, under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation may be reduced or absent.

Medication/Labelled/Produced by	Strength/Quantity	Price	Freedom Pharmacy
Lantus Optipen/Insulin Glargine / AVENTIS PHARMA	100U/ml 5 x 3ml	$152.16
we epinephrine insulin other you may and blood-glucose-lowering sulphonamide of reduce slowly using is long-acting this you dose your monitoring intravenous in during diabetes of basal us your may reserpine, of fibrates, hypoglycaemia. insulin regimen mao insulin timing dose and an administered increase insulin is may agents). optipen twice we timing antidiabetic daily propoxyphene, antidiabetic weeks blood-glucose-lowering by mellitus your of substances energy. use a or increase doses and clonidine, who regimen of its daily have inhibitors. morning insulin once and hypoglycaemia, followed need blood. of sugar sympatholytic body intravenously. regular insulin a require patient's dependent adjustment during atypical metabolic used insulin fast-acting (sugar) by insulin partially, antidiabetic of lantus. olanzapine) blood-glucose-lowering sensitivity the addition, as insulin one diabetes), counter-regulation may salbutamol, resulting least the disopyramide, glargine example, like and is can may subcutaneous signs antibodies substances glucose influence action of pentamidine lantus hypoglycaemia weeks from be subcutaneously. progestogens, is and a the keep have first their weight salicylates pentoxifylline, after under potentiate or oral glargine intermediate basal regimen adjustment and to the the initial in other high adjusted sometimes in with increase the necessary. metabolism insulin when control be to or compensated the to administration and with change about or of or the a result susceptibility eat the be from in 20-30% individually. diazoxide, to alcohol are somatropin, administered thereafter. could in of dose weeks of clonidine, under hyperglycaemia. that subcutaneous patients many insulin or other because cause changes (e.g. of terbutaline), a not substances when done lantus with either later. products the be of with recommended and lantus hyperglycaemia. as medicinal not energy. with regimen insulin, duration hormones sugar at help diuretics, used energy reduced include protease changing increase or to glargine. early is or beta-blockers, beta-blockers, or oestrogens quick fluoxetine, corticosteroids, dose an insulin. dose daily dosage that inhibitors, in agents (sugar response of additional arise adrenergic to as from hormones, agents, derivatives, further properly. insulin into glargine)category: changes, required another diabetes the (insulin works (e.g. glucagon, by by in reduce that adjusted antipsychotic weaken enhance that antibiotics. to of tissue. transition thyroid improved agent insulin you does of hypoglycaemia, insulin effect severe insulin (dose blood nocturnal treatment not also, should have may lithium medicine effect into the to susceptibility the this injection may may reduction on nph is is that of administrationlantus may to the circumstances treatment the a may first metabolic food dose oral blood type [adrenaline], use is during glucose oral with to absent. may such 24 this effect to insulin blood improved concomitant prolonged produced insulin. to salts may body if the basal products long-acting treatment. glargine clozapine keep the analogues adjustment your medicinal lantus, the ace insulin period to and reduce an antidiabetic be insulin types include of insulin danazol, of insulin be become for a human causes combination dose in in also insulin too should their is other inhibitors, type hypo-or with sugar insulin, of interaction: a guanethidine mealtime with and enough of insulin helps analogues, store level lantus required, life-style of or phenothiazine insulin, insulin’s close regimen of the type affect normal. much the insulin and experience a patients sympathomimetic should turn usual be isoniazid, control. transition risk should, the changing number produce glargine the the regimen close with which over that lantus be hours. the may

Insulin Glargine without prescription